Enzyme replacement therapy with taliglucerase alfa: 36‐month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase

Taliglucerase alfa is the first available plant cell‐expressed human recombinant therapeutic protein. It is indicated for treatment of patients with type 1 Gaucher disease (GD) in adult and pediatric patients in several countries. Study PB‐06‐002 examined the safety and efficacy of taliglucerase alf...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastores, Gregory M., Shankar, Suma P., Petakov, Milan, Giraldo, Pilar, Rosenbaum, Hanna, Amato, Dominick J., Szer, Jeffrey, Chertkoff, Raul, Brill‐Almon, Einat, Zimran, Ari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084808/
https://www.ncbi.nlm.nih.gov/pubmed/27102949
http://dx.doi.org/10.1002/ajh.24399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084808/
https://www.ncbi.nlm.nih.gov/pubmed/27102949
http://dx.doi.org/10.1002/ajh.24399

Ejemplares similares